Eversept Partners LP Sells 6,943 Shares of Intuitive Surgical, Inc. $ISRG

Eversept Partners LP decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 38.4% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,119 shares of the medical equipment provider’s stock after selling 6,943 shares during the quarter. Eversept Partners LP’s holdings in Intuitive Surgical were worth $5,126,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Brighton Jones LLC raised its stake in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after buying an additional 731 shares during the last quarter. Sivia Capital Partners LLC boosted its stake in shares of Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after buying an additional 34 shares during the last quarter. Schnieders Capital Management LLC. boosted its stake in shares of Intuitive Surgical by 38.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after buying an additional 268 shares during the last quarter. Osterweis Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the second quarter worth $200,000. Finally, Main Street Financial Solutions LLC grew its holdings in shares of Intuitive Surgical by 92.4% in the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after acquiring an additional 1,407 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $356.83 on Tuesday. The stock has a market capitalization of $126.06 billion, a price-to-earnings ratio of 40.87, a PEG ratio of 2.44 and a beta of 1.46. The company has a fifty day moving average of $405.22 and a 200 day moving average of $457.57. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The company had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.81 earnings per share. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. The Goldman Sachs Group set a $558.00 price target on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Tuesday, May 19th. TD Cowen reduced their target price on shares of Intuitive Surgical from $585.00 to $520.00 and set a “buy” rating for the company in a report on Monday, July 13th. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. Twenty-one equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $519.13.

Insider Buying and Selling

In related news, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. This trade represents a 46.53% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the business’s stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This trade represents a 49.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 6,669 shares of company stock valued at $2,822,405 in the last 90 days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.